Biomedical Engineering Reference
In-Depth Information
126. Pitsiou G, Kyriazis G, Hatzizisi O, Argyropoulou P, Mavrofridis E, Patakas
D. Tumor necrosis factor-a serum levels, weight loss and tissue oxygenation in
chronic obstructive pulmonary disease. Respir Med 2002; 96:594-598.
127. Langen RC, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger YM.
Inflammatory cytokines inhibit myogenic differentiation through activation
of nuclear factor-
k
B. FASEB J 2001; 15:1169- 1180.
128. Barnes PJ. Cytokine modulators as novel therapies for airway disease. Eur
Resp J 2001; 18:67S-77S.
129. Rabinovich RA, Figueras M, Ardite E, Carbo N, Troosters T, Filella X, et al.
Increased tumour necrosis factor-
a
plasma levels during moderate-intensity
exercise in COPD patients. Eur Respir J 2003; 21:789-794.
130. Russell RE, Thorley A, Culpitt SV, Dodd S, Donnelly LE, Demattos C, et al.
Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases,
cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol 2002;
283:L867-L873.
131. Rusznak C, Mills PR, Devalia JL, Sapsford RJ, Davies RJ, Lozewicz S. Effect
of cigarette smoke on the permeability and IL-1
b
and sICAM-1 release from
cultured human bronchial epithelial cells of never-smokers, smokers, and
patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol
Biol 2000; 23:530-536.
132. Rupp J, Kothe H, Mueller A, Maass M, Dalhoff K. Imbalanced secretion of
IL-1beta and IL-1RA in Chlamydia pneumoniae-infected mononuclear cells
from COPD patients. Eur Respir J 2003; 22:274-279.
133. Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA. Relation of sputum
inflammatory markers to symptoms and lung function changes in COPD
exacerbations. Thorax 2000; 55(2):114-120.
134. Song W, Zhao J, Li Z. lnterleukin-6 in bronchoalveolar lavage fluid from
patients with COPD. Chin Med J 2001; 114:1140-1142.
135. Bucchioni E, Kharitonov SA, Allegra L, Barnes PJ. High levels of interleukin-
6 in the exhaled breath condensate of patients with COPD. Respir Med 2003;
97:1299-1302.
136. Wedzicha JA, Seemungal TA, MacCallum PK, Paul EA, Donaldson GC,
Bhowmik A, et al. Acute exacerbations of chronic obstructive pulmonary
disease are accompanied by elevations of plasma fibrinogen and serum IL-6
levels. Thromb Haemost 2000; 84:210-215.
137. Debigare R, Marquis K, Cote CH, Tremblay RR, Michaud A, Leblanc P,
et al. Catabolic
=
anabolic balance and muscle wasting in patients with COPD.
Chest 2003; 124:83-89.
138. Balbi B, Bason C, Balleari E, Fiasella F, Pesci A, Ghio R, et al. Increased
bronchoalveolar granulocytes and granulocyte
=
macrophage colony-stimulat-
ing factor during exacerbations of chronic bronchitis. Eur Respir J 1997;
10:846-850.
139. Barnes PJ. IL-10: a key regulator of allergic disease. Clin Exp Allergy 2001;
31:667-669.
140. Takanashi S, Hasegawa Y, Kanehira Y, Yamamoto K, Fujimoto K, Satoh K,
et al. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD
and in smokers. Eur Respir J 1999; 14:309-314.
